SummitTX Capital L.P. Sells 330,476 Shares of Healthpeak Properties, Inc. $DOC

SummitTX Capital L.P. lessened its position in Healthpeak Properties, Inc. (NYSE:DOC) by 28.1% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 846,258 shares of the real estate investment trust’s stock after selling 330,476 shares during the period. SummitTX Capital L.P.’s holdings in Healthpeak Properties were worth $13,904,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the company. WPG Advisers LLC boosted its stake in shares of Healthpeak Properties by 270.2% during the fourth quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust’s stock valued at $26,000 after purchasing an additional 1,197 shares in the last quarter. Advocate Investing Services LLC bought a new stake in shares of Healthpeak Properties during the fourth quarter worth about $26,000. Elyxium Wealth LLC acquired a new position in shares of Healthpeak Properties in the fourth quarter valued at approximately $31,000. Clearstead Advisors LLC increased its stake in shares of Healthpeak Properties by 166.3% in the fourth quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust’s stock valued at $31,000 after buying an additional 1,216 shares during the period. Finally, CYBER HORNET ETFs LLC bought a new position in Healthpeak Properties in the 2nd quarter valued at approximately $33,000. 93.57% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total transaction of $213,736.05. Following the completion of the sale, the insider directly owned 7,636 shares in the company, valued at approximately $148,520.20. This trade represents a 59.00% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.23% of the company’s stock.

Analyst Ratings Changes

Several research firms recently commented on DOC. Mizuho lifted their target price on shares of Healthpeak Properties from $21.00 to $24.00 and gave the stock an “outperform” rating in a research report on Monday, July 6th. Robert W. Baird lifted their price target on shares of Healthpeak Properties from $19.00 to $21.00 and gave the stock an “outperform” rating in a report on Wednesday, May 13th. Weiss Ratings raised shares of Healthpeak Properties from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, May 8th. JPMorgan Chase & Co. raised their target price on Healthpeak Properties from $18.00 to $21.00 and gave the stock a “neutral” rating in a research report on Wednesday, June 24th. Finally, Scotiabank lifted their target price on Healthpeak Properties from $19.00 to $21.00 and gave the stock a “sector perform” rating in a report on Wednesday, May 27th. Four equities research analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Healthpeak Properties has an average rating of “Hold” and a consensus target price of $20.62.

Healthpeak Properties Stock Up 0.1%

Shares of NYSE DOC opened at $22.29 on Monday. The company has a market capitalization of $15.37 billion, a P/E ratio of 69.67, a price-to-earnings-growth ratio of 3.46 and a beta of 1.02. Healthpeak Properties, Inc. has a 52-week low of $15.70 and a 52-week high of $22.77. The company has a debt-to-equity ratio of 1.15, a quick ratio of 2.96 and a current ratio of 2.96. The company’s 50 day moving average price is $20.74 and its 200-day moving average price is $18.47.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.02. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The company had revenue of $752.95 million during the quarter, compared to analysts’ expectations of $694.59 million. During the same period in the prior year, the company posted $0.46 earnings per share. Healthpeak Properties’s revenue for the quarter was up 7.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Equities analysts forecast that Healthpeak Properties, Inc. will post 1.75 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The company also recently declared a monthly dividend, which will be paid on Friday, September 25th. Shareholders of record on Monday, September 14th will be given a dividend of $0.1017 per share. The ex-dividend date of this dividend is Monday, September 14th. This represents a c) dividend on an annualized basis and a yield of 5.5%. Healthpeak Properties’s dividend payout ratio is 381.25%.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.